Development of a new biodegrable intravascular polymer stent with simultaneous incorporation of bioactive substances

International Journal of Artificial Organs

Volumn 22, Issue 12, 1999, Pages 843-853

  Blindt, R ^b   Hoffmeister, K M ^b   Bienert, H ^b   Pfannschmitt, O ^b   Bartsch, G ^b   Thissen, H ^a   Klee, D ^a   Vom Dahl, J ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b NONE

Author keywords

Angioplasty; Cell culture; Cellular; Computer modelling; Experimental; Heart; Molecular biology stent; Restenosis

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; CARBON DIOXIDE; CONTROLLED DRUG DELIVERY; FINITE ELEMENT METHOD; FUNCTIONAL POLYMERS; GLASS TRANSITION; INERT GASES; MOLECULAR BIOLOGY; POLYESTERS; POLYMER BLENDS; POLYMERIC IMPLANTS; STENTS; SYNTHETIC POLYMERS; TARGETED DRUG DELIVERY;

ANGIOPLASTY; BIOACTIVE SUBSTANCES; CELLULARS; COMPUTER MODELS; DRUG RELEASE; EXPERIMENTAL; L-LACTIDE; MOLECULAR BIOLOGY STENT; RESTENOSIS; THERMALLY SENSITIVES;

CELL CULTURE;

CARBON DIOXIDE; DRUG ADDITIVE; POLYGLACTIN; POLYMER; BIOMATERIAL; POLYESTER; POLYLACTIDE;

ANGIOPLASTY; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPUTER MODEL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; MOUSE; NONHUMAN; RESTENOSIS; STENT; THROMBOGENICITY; BIODEGRADABLE IMPLANT; BLOOD VESSEL PROSTHESIS; CELL CULTURE; COMPUTER SIMULATION; PROSTHESIS;

ABSORBABLE IMPLANTS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; CELLS, CULTURED; COMPUTER SIMULATION; POLYESTERS; POLYMERS; PROSTHESIS DESIGN; STENTS;

EID: 0033233209     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889902201211     Document Type: Article

References (27)

1. Gruentzig AR, Senning A, Siegenthaler WE. Nonopreative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-8.
2. Weintraub WS, Ghazzal ZM, Douglas JS Jr, et al. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty. Circulation 1993; 87: 831-40.
3. Lincoff AM, Tcheng JE, Ellis SG, et al. Randomized trial of platelet glycoprotein IIb/IIIa inhibition with Integrelin (TM) for prevention of restenosis following coronary intervention: the Impact II angiographic substudy (Abstract). Circulation 1997; 96: I-607.
4. Ellis SG, Serruys PW, Popma JJ, et al. Can abciximab prevent neointimal proliferation in Palmatz-Schatz stents? The final ERASER results (Abstract). Circulation 1997; 96: I-607.
5. Fischmann DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery desease. N Engl J Med 1994; 331: 496-50.
6. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 8: 489-95.
7. Kastrati A, Schuehlen H, Hausleiter J, et al. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the intracoronary stenting and antithrombotic regimen (ISAR) trial. Circulation 1997; 96: 362-7.
8. EPISTENT Investigators. Randomised placebo controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb-IIIa blockade. Lancet 1998; 352-87-92.
9. Narins CR, Holmes DR, Topol EJ. A call for provisional stenting. The balloon is back! Circulation 1998; 97: 1298-305.
10. De Jaegere PT. Endovascular stents: preliminary clinical results and future developments. Clin Cardiol 1993; 16: 369-78.
11. Agrawal CM, Haas KF, Clark HG. Evaluation of Poly(L-lactide acid) as material for intravascular polymeric stents. Biomaterials 1992; 13: 176-82.
12. Zhang XC. Biodegradable lactide polymers: synthesis, degradation and drug controlled release properties. Kingston, Canada: Queen's University. 1993. PhD thesis.
13. Kemppainen E, Taija M, Riihela M, Pohlonen T, Tormala P, Alfthan O. A bioresorbable urethral stent. Urol Res 1993; 32: 235-8.
14. Vert M, Li MG, Spenlehauer G, Guerin P. Bioresorbability and biocompatibility of aliphatic polymers. Journal of Material Science in Medicine 1992; 3: 432-46.
15. Elgendy HM, Norman ME, Keaton AR, Laurencin CT. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material. Biomaterials 1993; 14, 4: 263-9.
16. Leenslang JW, Pennings AJ, Bos RR, Rozema FR, Boering G. Resorbable materials of poly(L-lactide). Plates and screws for internal fracture fixation. Biomaterials 1987; 8: 70-3.
17. Van Sliedregt A, Radder AM,De Groot K, Van Blitterswijk CA. In vitro biocompatibility testing of polylactides Part I: Proliferation of different cell types. J Mater Sci: Mater Med 1992; 3: 365-70.
18. Peng T, Gibula P, Yao KD, et al. Role of polymers in improving the results of stenting in coronary arteries. Biomaterials 1996; 17: 685-94.
19. Lincoff AM, Furst JG, Ellis SG, Topol EJ. Sustained local drug delivery by a novel intravascualr eluting stent to prevent restonosis in the porcine coronary artery. J Am Coll Cardiol 1994; 23 (suppl A) : 18. (Abstract).
20. III and osteopontin expression during neointima formation. Cardvasc Res 1997; 36: 408-28.
21. von Oepen R. Development of specific engineering and fabrication techniques for the production of degradable implants. Aachen, Germany, RWTH Aachen. 1193. PhD thesis.
22. Seibt S. Fundamentals and applications of gas loading for resorbable polyesters. Aachen, Germany, RWTH Aachen, 1996. PhD Thesis.
23. Ciapetti G, Cenni E, Pratelli L, Pizzoferrato A. In vitro evaluation of cell/biomaterial interaction by MTT assay. Biomaterials 1993; 14: 359-63.
24. Murphy JG, Schwartz RS, Huber KC, Holmes DR. Polymeric stents: modern alchemy or the future? J invasive Cardiol 1991; 3: 144-8.
25. Ignatius AA, Claes LE. In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glucolide). Biomaterial 1996; 17: 831-9.
26. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17: 2: 93-102.
27. Giessen WJ, Lincoff AM, Schwrtz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996: 94: 1690-7.